Professional Documents
Culture Documents
Table Of Contents
Issuance Proceeds To Refinance Debt, Invest In Growth Mostly Stable Outlooks Consumer Products Forecast: General Financial Stability Despite Meaningful Debt Issuance Retail And Restaurant Forecast: General Financial Stability Despite Some Uneven Performances And A Still Cautious Consumer Health Care Forecast: General Financial Stability, But Some Erosion Could Stem From The Affordable Care Act Related Criteria And Research
WWW.STANDARDANDPOORS.COM/RATINGSDIRECT
Debt Issuance And M&A Notwithstanding, Outlook For U.S. Consumer, Retail, And Health Care Sectors Is Stable
Despite years of substantial debt issuance and large mergers and acquisitions (M&A), U.S. consumer products, retail, and health care (CRH) companies, in general, appear to be in relatively good financial shape. Although debt issuance is likely to carry on in these sectors through at least 2014, Standard & Poor's Ratings Services expects EBITDA growth to generally keep pace, and that companies will deploy the vast majority of the funds from the new debt to refinance existing debt or support growth initiatives. This should translate into a generally stable rating environment for these sectors. Overview Across the U.S. consumer products, retail, and health care (CRH) sectors, we assess the ratings outlook to be stable for about 87% of the rated companies. CRH issuers are likely to continue to opportunistically refinance debt while interest rates remain low, and to deploy new debt to support growth through investments in their business. For the consumer products, retail, and restaurant sectors, we expect credit metrics to remain relatively stable as EBITDA growth keeps pace with increased debt. Though financial profiles will remain generally stable for the vast majority of the health care sector, continued leveraged M&A activity and revenue pressure combined with the limits of continued cost cutting could create some erosion.
As the U.S. economic recovery gains momentum, rated CRH companies are likely to take continued advantage of low interest rates and the generally favorable capital markets environment. Debt issuance, according to our framework for forecasting global debt demand, could be as follows: Projected Debt Demand 2013-2014
For 2013-2014 New Debt Demand 2012 Total Debt Consumer Retail Health care Total CRH $405 bil. $278 bil. $469 bil. $1,152 bil. Refinancing Demand* $116 bil. $79 bil. $134 bil. $329 bil. Nominal GDP 5.1% 5.1% 5.1% -1x Nominal GDP Growth $42 bil. $29 bil. $49 bil. $120 bil. 1.2x Nominal GDP Growth $51 bil. $35 bil. $59 bil. $145 bil. Total Debt Issuance 1x Nominal GDP Growth $158 bil. $109 bil. $183 bil. $450 bil. 1.2x Nominal GDP Growth $167 bil. $115 bil. $193 bil. $475 bil.
*Estimated refinancing for debt maturities and opportunistic transactions in advance of maturities; calculated on a pro rata basis over an average seven-year period. So for two years, it is 2/7. Based on International Monetary Fund April 2013 projections.
WWW.STANDARDANDPOORS.COM/RATINGSDIRECT
Debt Issuance And M&A Notwithstanding, Outlook For U.S. Consumer, Retail, And Health Care Sectors Is Stable
Consumer Products Forecast: General Financial Stability Despite Meaningful Debt Issuance
The consumer products sector saw issuance of about $95 billion to $100 billion annually for 2012 and 2011, roughly double the level of issuance during the recent recession. Debt issuance during the first half of 2013 is on track to surpass 2012 issuance, due in part to refinancing and large M&A transactions. Though we expect rated consumer products companies to use the bulk of the proceeds to refinance existing debt, they will also likely raise new debt to
WWW.STANDARDANDPOORS.COM/RATINGSDIRECT
Debt Issuance And M&A Notwithstanding, Outlook For U.S. Consumer, Retail, And Health Care Sectors Is Stable
support growth and--to a lesser extent--fund shareholder distributions. With the cost of borrowing remaining low, we expect M&A activity to remain similar to the moderate 2012 levels, with significant deal volume in the food and beverage subsectors, which have been consistently merging and acquiring. Large recent transactions include the February 2013 Heinz leveraged buyout (by Berkshire/3G), Hormels purchase of Skippy from Unilever, and the proposed purchase of Hostess' assets by both strategic and financial buyers. The agribusiness sector has also been active lately, as demonstrated by Smithfield's May announcement that it would be acquired by a Chinese buyer. And bolt-on acquisitions will probably continue--especially involving emerging markets, where many companies are seeking growth outside of slower growth developed markets. We also expect companies to continue to support growth with investment in their brands as well as some capital expenditure needs. While there was a pull back on investment during the last recession, we do not believe there has been material underinvestment in the sector. Overall, we expect shareholder distribution activity to be leverage-neutral for the consumer products sector and substantially funded with cash sources. But we have seen some increase in leveraged shareholder distributions by speculative-grade, sponsor-owned firms.
Retail And Restaurant Forecast: General Financial Stability Despite Some Uneven Performances And A Still Cautious Consumer
We expect debt issuance for 2013 and 2014 to continue to be steady, but slightly below the over $65 billion level annually for the past three years (roughly three times the average issuance during the 2008-2009 recessionary period). Debt issuance for the first half of 2013 for rated retailers and restaurants is tracking to be modestly lower than 2012 issuance. We expect companies to use the vast majority of the proceeds from debt issuance to refinance existing debt and fund shareholder distributions. We also expect retail and restaurant companies to use some debt to support capital expenditures and larger M&A activities. We believe certain subsegments will borrow to invest in stores and infrastructure, including e-commerce and omni-channel capabilities. Still, we do not believe there is significant catch-up investment needed in the sector's store footprint stemming from the last recession. We estimate strategic M&A activity for 2013 to be somewhat light and similar to 2012. Announced deals so far in 2013 includes the large merger of office superstores Office Depot and OfficeMax (an all-stock transaction), Kroger's $2.5
WWW.STANDARDANDPOORS.COM/RATINGSDIRECT
Debt Issuance And M&A Notwithstanding, Outlook For U.S. Consumer, Retail, And Health Care Sectors Is Stable
billion acquisition of a regional supermarket chain, as well as a realignment of ownership in the supermarket segment (akin to a series of divestitures), including Safeway's sale of its Canadian operations. In most markets, we think there is an oversupply of retail space. While in many industries oversupply can spur M&A in the right economic climate, in retail, consolidation is often expensive and slow given the extensive use of leases in the sector. We expect activity by private-equity-owned companies to remain steady as a number of private-equity-owned companies have increased leverage through either a dividend or sale to another sponsor.
Health Care Forecast: General Financial Stability, But Some Erosion Could Stem From The Affordable Care Act
Following significant debt issuance over the past few years, peaking at about $150 billion in 2011, issuance for the first half of 2013 for rated health care companies is on track to be similar to 2012 levels in the $120 billion area. While the vast majority of the proceeds from debt issuance will likely be used to refinance existing debt, companies will also likely raise new debt for M&A activity and shareholder distributions, for private equity-owned companies and large multinationals. Funding needs for capital expenditures is minimal for the sector given the strong cash flow generation and the low capital-intensity of the business. Organic growth rates remain sluggish for the sector, so we expect M&A activity to remain high for 2013. Volume is on track to outpace that of 2012, when there were five multibillion dollar transactions, predominately in pharmaceuticals; six sizable transactions have been announced already. Large recent transactions include Thermo Fishers acquisition of Life Technologies for $14 billion, Valeants acquisition of Bausch & Lomb for $8.7 billion, and Actavis' acquisition of Warner Chilcott for $8.5 billion. The transactions (with the exception of Actavis' 100% equity funded transaction) are substantially funded with debt, given the low interest rates. The main activity drivers are pricing pressure from government payors, the need for pharmaceutical companies to replace revenues lost to patent expiration, and the active role of private equity investors (which is always very prominent in this sector).
WWW.STANDARDANDPOORS.COM/RATINGSDIRECT
Debt Issuance And M&A Notwithstanding, Outlook For U.S. Consumer, Retail, And Health Care Sectors Is Stable
assess liquidity to be adequate or better for roughly 93% of the rated healthcare companies.
WWW.STANDARDANDPOORS.COM/RATINGSDIRECT
Copyright 2013 by Standard & Poor's Financial Services LLC. All rights reserved. No content (including ratings, credit-related analyses and data, valuations, model, software or other application or output therefrom) or any part thereof (Content) may be modified, reverse engineered, reproduced or distributed in any form by any means, or stored in a database or retrieval system, without the prior written permission of Standard & Poor's Financial Services LLC or its affiliates (collectively, S&P). The Content shall not be used for any unlawful or unauthorized purposes. S&P and any third-party providers, as well as their directors, officers, shareholders, employees or agents (collectively S&P Parties) do not guarantee the accuracy, completeness, timeliness or availability of the Content. S&P Parties are not responsible for any errors or omissions (negligent or otherwise), regardless of the cause, for the results obtained from the use of the Content, or for the security or maintenance of any data input by the user. The Content is provided on an "as is" basis. S&P PARTIES DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING, BUT NOT LIMITED TO, ANY WARRANTIES OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE OR USE, FREEDOM FROM BUGS, SOFTWARE ERRORS OR DEFECTS, THAT THE CONTENT'S FUNCTIONING WILL BE UNINTERRUPTED, OR THAT THE CONTENT WILL OPERATE WITH ANY SOFTWARE OR HARDWARE CONFIGURATION. In no event shall S&P Parties be liable to any party for any direct, indirect, incidental, exemplary, compensatory, punitive, special or consequential damages, costs, expenses, legal fees, or losses (including, without limitation, lost income or lost profits and opportunity costs or losses caused by negligence) in connection with any use of the Content even if advised of the possibility of such damages. Credit-related and other analyses, including ratings, and statements in the Content are statements of opinion as of the date they are expressed and not statements of fact. S&P's opinions, analyses, and rating acknowledgment decisions (described below) are not recommendations to purchase, hold, or sell any securities or to make any investment decisions, and do not address the suitability of any security. S&P assumes no obligation to update the Content following publication in any form or format. The Content should not be relied on and is not a substitute for the skill, judgment and experience of the user, its management, employees, advisors and/or clients when making investment and other business decisions. S&P does not act as a fiduciary or an investment advisor except where registered as such. While S&P has obtained information from sources it believes to be reliable, S&P does not perform an audit and undertakes no duty of due diligence or independent verification of any information it receives. To the extent that regulatory authorities allow a rating agency to acknowledge in one jurisdiction a rating issued in another jurisdiction for certain regulatory purposes, S&P reserves the right to assign, withdraw, or suspend such acknowledgement at any time and in its sole discretion. S&P Parties disclaim any duty whatsoever arising out of the assignment, withdrawal, or suspension of an acknowledgment as well as any liability for any damage alleged to have been suffered on account thereof. S&P keeps certain activities of its business units separate from each other in order to preserve the independence and objectivity of their respective activities. As a result, certain business units of S&P may have information that is not available to other S&P business units. S&P has established policies and procedures to maintain the confidentiality of certain nonpublic information received in connection with each analytical process. S&P may receive compensation for its ratings and certain analyses, normally from issuers or underwriters of securities or from obligors. S&P reserves the right to disseminate its opinions and analyses. S&P's public ratings and analyses are made available on its Web sites, www.standardandpoors.com (free of charge), and www.ratingsdirect.com and www.globalcreditportal.com (subscription) and www.spcapitaliq.com (subscription) and may be distributed through other means, including via S&P publications and third-party redistributors. Additional information about our ratings fees is available at www.standardandpoors.com/usratingsfees.
WWW.STANDARDANDPOORS.COM/RATINGSDIRECT